Company intelligence / Profile preview

StradBio

Seattle, Washington, United Statesstradbio.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

StradBio develops next-generation immunotherapies using precision-engineered immune agonists to activate the immune system against cancer and inflammatory diseases. Their proprietary platforms aim to maximize efficacy while minimizing side effects by controlling where and how potent immune signals are delivered. The company leverages computational protein design, logic gating, and targeted delivery for improved safety profiles. No clinical results have been published yet; programs appear preclinical.

Therapeutic areas
OncologyImmunology
Modalities
Precision-tuned cytokine mimetics (de novo designed proteins)Split cytokine technology (conditional activation)Locked cytokine technology (site-specific chemical modification)
Industry
Biotech
02

Drug pipeline

2 assets

Daiad-2/15

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on StradBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on StradBio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call